FDA Approves Phase II Kidney Cancer Therapy Study
13 sept. 2021 18h41 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug...
Cancer Immunotherapy Documentary Wins Prestigious Golden Owl Award at Bergen International Film Festival
08 oct. 2019 09h00 HE
|
Uncommon Productions
Boston, MA, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Uncommon Productions (“Uncommon”) is proud to announce that their latest documentary, Jim Allison: Breakthrough (“Breakthrough”) has received the 2019...
UPDATED RELEASE: Rafael Pharmaceuticals Announces Initiation of Patient Enrollment for Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia
09 janv. 2019 13h15 HE
|
Rafael Pharmaceutical Inc.
Newark, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of patient...
First Patient Imaged in Prostate Imaging Study
12 août 2018 18h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
CipherHealth Celebrates the Work of Exceptional Nurses with Award
30 mai 2018 08h55 HE
|
CipherHealth
New York, New York, May 30, 2018 (GLOBE NEWSWIRE) -- CipherHealth, a leading healthcare patient engagement technology company, has recognized exceptional nurse or nursing teams across the country...
Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration
13 déc. 2017 17h30 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...
Local Crush Cancer Event on May 7, Benefiting Cycle for Survival, Will Raise Funds for Rare Cancer Research
26 avr. 2017 13h41 HE
|
Crush Cancer
VIRGINIA BEACH, Va., April 26, 2017 (GLOBE NEWSWIRE) -- Crush Cancer, benefiting Cycle for Survival, the movement to beat rare cancers, will host its third annual indoor cycling event Sunday, May...